A clinical study of bojungikgitang and banhabaekchulchonmatang in adult tinnitus patients: a randomised, double-blind, three-arm, placebo-controlled trial

Korea Health Industry Development Institute (KHIDI) (South Korea)0 个研究点目标入组 120 人开始时间: 2009年6月5日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Age greater than 19 years, either sex
•2. Typical conditions of intermittent or continuous tinnitus
•2.1. The duration of more than 3 months
•2.2. Involuntary perception of the concept of a sound without the presence of an external source
•3. Agreed not to receive another treatment during the clinical trial period
•4. Written and informed consent

•1. Receiving other forms of tinnitus treatments
•2. Underlying disease or history:
•2.1. Otitis media
•2.2. Acoustic tumour
•2.3. Intracranial lesion
•2.4. Inner ear malformation
•2.5. Head trauma
•2.6. Ototoxic drug medication, etc.
•3. Women in pregnacy and lactation or without contraception
•4. Other clinical trial within the last 1 month
•5. Auditory surgery, a major surgery or a blood transfusion within the last 1 month
•6. Hypersensitiveness or allergy of drugs
•7. Disease which can affect the absorption of drugs or disordered digestion after surgery related to the disease
•8. History of neuropsychitric abnormality:
•8.1. Manic-depression
•8.2. Schizophrenia
•8.3. Alcoholism
•8.4. Drug addiction, etc.
•9. Cannot understand a written consent or follow this study:
•9.1. Mental retardation
•9.2. Mental or emotional problems
•10. Judged by expert that they are inappropriate to participate in this study

发起方

Korea Health Industry Development Institute (KHIDI) (South Korea)